Drug Testing Locations - Alamance, NC

Drug Testing in Alamance, NC

Alamance, North Carolina Statistics

In Alamance County, NC, opioid-related overdose deaths increased by 15% in 2022.

Alamance, NC reported 400 drug-related emergency room visits in 2022.

In 2022, Alamance County law enforcement seized over 300 pounds of illegal narcotics.

Drug court participants in Alamance County showed a 70% decrease in recidivism rates in 2022.

Alamance, NC documented a 25% rise in fentanyl-related incidents last year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Alamance, NC & Drug Testing Policies

In Alamance County, NC, employers have implemented strict drug testing policies to maintain workplace safety. Companies may conduct pre-employment, random, or post-accident drug screenings as part of their health and safety protocols, aligning with state laws.

These policies are overseen by regulations from the North Carolina Department of Labor, which provides guidelines and resources available at their website. Businesses emphasize employee assistance programs for prevention and support, integrating educational resources to minimize workplace drug issues.

Employers in Alamance, NC are increasingly recognizing the impact of drug abuse on productivity and workplace health, prompting proactive measures in collaboration with health care providers and counseling services.

Government Efforts with Drug Problems in Alamance, NC

Alamance County, NC has been actively involved in battling drug abuse through several initiatives. The county aids various organizations that provide treatment and prevention programs, focusing on education and rehabilitation. Collaborations with law enforcement agencies aim to reduce drug-related crimes.

The U.S. Department of Health and Human Services offers resources via their website, and state agencies like the North Carolina Department of Health and Human Services also play a crucial role. Local organizations work alongside government bodies to provide necessary support to those affected.

Local Drug Busts & News in Alamance, NC

In recent years, Alamance County experienced significant drug busts aimed at curbing the spread of illegal substances. In 2023, a major operation led by local law enforcement seized illicit drugs valued at over $500,000, illustrating the ongoing battle against narcotics distribution within the community.

Community events hosted throughout the year, such as "Drug Take-Back" days, provide opportunities for residents to safely dispose of unused medications, reducing potential abuse. Such initiatives reflect the county's commitment to addressing drug-related problems and promoting public health.

Collaboration between community members, law enforcement, and public health officials is crucial in organizing events that educate and provide resources to those affected by drug use in Alamance County, leading to a more informed and resilient community.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Alamance, NC. Trusted by employers nationwide for accurate results and exceptional service.

North Carolina DOT/Non DOT Physicals

North Carolina Vision Tests

North Carolina Audiograms

North Carolina Respirator Fit Tests

North Carolina Lift Tests

North Carolina Background Checks

Clinical Testing Services

TB Testing in NC

Diabetes Testing in NC

Infectious Disease Testing in NC

Sickle Cell Anemia Testing in NC

Women/Men's Health Testing in NC

Resources & Citations

North Carolina Department of Health and Human Services

Alcohol and Drug Council of North Carolina

Alamance County Health Services

CRC Health

North Carolina Harm Reduction Coalition

Triangle Behavioral Health

Project Lazarus

CDC Drug Overdose

Drug Testing Near Alamance, NC

Altamahaw, NC

Ossipee, NC

Whitsett, NC

Gibsonville, NC

Saxapahaw, NC

Mebane, NC

Woodlawn, NC

Elon College, NC

Elon, NC

Glen Raven, NC

Green Level, NC

Burlington, NC

Haw River, NC

Bellemont, NC

Swepsonville, NC

Frequently Asked Questions

Customer Reviews